Session Details

U096 Multimodal Cosmetic Treatments: What to Combine When and How

Mon, Mar 30, 7:30 AM - 8:30 AM
Mile HIgh 1A
1 CME Available Focus Session
View Map

DESCRIPTION

Each of the participants will lecture on different multimodal treatments and the timing they suggest for the different combinations of treatments. One lecture will focus on laser and light source treatments; one will focus on skin of color multimodal treatments. After each of these lectures there will be an informal question and answer session. The lectures will be divided by types of devices and different types of fillers. There may be division of treatment plans based on anatomical areas as well.

LEARNING OBJECTIVES

1.

Choose the proper order to deliver cosmetic treatments and lasers in same day treatments

2.

Develop a multimodal treatment plan for patients after a proper evaluation

3.

Determine the timing of properly treating patients with different fillers/toxins/lasers/threads

SCHEDULE

7:30 AM

Multimodal same day treatment approach to traumatic scars

Emily Guo, MD, FAAD

7:45 AM

Stepwise approach to photodamage

Jameson Taylor Loyal, MD, FAAD

8:00 AM

Combined approach to treating rosacea

Alyx Cali Rosen Aigen, MD, FAAD

8:15 AM

Optimizing the timing of every modality

Zakia Rahman, MD, FAAD

DIRECTOR

Alyx Cali Rosen Aigen, MD, FAAD

Alyx Cali Rosen Aigen, MD, FAAD

SPEAKERS

Emily Guo, MD, FAAD

Emily Guo, MD, FAAD

Dermatology & Laser Surgery Center

Jameson Taylor Loyal, MD, FAAD

Jameson Taylor Loyal, MD, FAAD

Zakia Rahman, MD, FAAD

Zakia Rahman, MD, FAAD

HANDOUTS

Login to view handouts

DISCLOSURES

Emily Guo, MD, FAAD

Acclaro Medical – Speaker(Honoraria); Solta Medical – Speaker(Honoraria);

Jameson Taylor Loyal, MD, FAAD

No financial relationships exist with ineligible companies.

Zakia Rahman, MD, FAAD

Allergan, Inc. – Advisory Board(Honoraria); Estee Lauder – Investigator(Grants/Research Funding); Laurette – Other(Stock);

Alyx Cali Rosen Aigen, MD, FAAD

No financial relationships exist with ineligible companies.